186 related articles for article (PubMed ID: 2953100)
1. Treatment of advanced prostatic cancer.
Sogani PC; Fair WR
Urol Clin North Am; 1987 May; 14(2):353-71. PubMed ID: 2953100
[TBL] [Abstract][Full Text] [Related]
2. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
3. Newer methods of hormonal therapy for prostate cancer.
Soloway MS
Urology; 1984 Nov; 24(5 Suppl):30-8. PubMed ID: 6437034
[TBL] [Abstract][Full Text] [Related]
4. Hormone therapy of prostatic bone metastases.
Huben RP
Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
[TBL] [Abstract][Full Text] [Related]
6. [Cancer of the prostate: new hormone therapies].
Namer M; Boublil JL; Kather R; Cavaglione G
Bull Cancer; 1986; 73(1):47-55. PubMed ID: 3779122
[TBL] [Abstract][Full Text] [Related]
7. Physiologic basis of endocrine therapy for prostatic cancer.
McConnell JD
Urol Clin North Am; 1991 Feb; 18(1):1-13. PubMed ID: 1899494
[TBL] [Abstract][Full Text] [Related]
8. Hormonal therapy in prostatic carcinoma.
Resnick MI
Urology; 1984 Nov; 24(5 Suppl):18-23. PubMed ID: 6388092
[TBL] [Abstract][Full Text] [Related]
9. Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Debruyne FM
Am J Clin Oncol; 1988; 11 Suppl 1():S33-5. PubMed ID: 2968760
[TBL] [Abstract][Full Text] [Related]
10. Treatment of prostatic cancer. Newer forms of androgen deprivation.
Soloway MS
Postgrad Med; 1986 Jul; 80(1):249-52, 257-8. PubMed ID: 2941729
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer.
Pummer K; Lehnert M; Stettner H; Hubmer G
Eur Urol; 1997; 32 Suppl 3():81-5. PubMed ID: 9267791
[TBL] [Abstract][Full Text] [Related]
12. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
13. [First line therapy in the treatment of metastatic prostate cancer].
Sakai H; Kanetake H
Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704
[TBL] [Abstract][Full Text] [Related]
14. New forms and future perspectives in endocrine treatment of prostatic carcinoma.
Jacobi GH; Wenderoth UK
Prog Clin Biol Res; 1984; 153():529-45. PubMed ID: 6236463
[No Abstract] [Full Text] [Related]
15. Hormone therapy of advanced prostate cancer: where we stand today.
Crawford ED; Nabors W
Oncology (Williston Park); 1991 Jan; 5(1):21-30; discussion 30, 32, 37. PubMed ID: 1828686
[TBL] [Abstract][Full Text] [Related]
16. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE
Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
[TBL] [Abstract][Full Text] [Related]
17. Endocrine therapy for prostate cancer.
Damber JE
Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920
[TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation therapy for prostate cancer: current status and future prospects.
Miyamoto H; Messing EM; Chang C
Prostate; 2004 Dec; 61(4):332-53. PubMed ID: 15389811
[TBL] [Abstract][Full Text] [Related]
19. Treatment of prostate cancer.
Korman LB
Clin Pharm; 1989 Jun; 8(6):412-24. PubMed ID: 2663330
[TBL] [Abstract][Full Text] [Related]
20. Use of cyproterone acetate in prostate cancer.
Goldenberg SL; Bruchovsky N
Urol Clin North Am; 1991 Feb; 18(1):111-22. PubMed ID: 1825143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
